Analysis of Biomarkers in Patients With Acute Myeloid Leukemia After Allogeneic Stem Cell Transplantation Treated With Menin Inhibition.
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The white blood cells of patients with acute myeloid leukemia that have undergone allogeneic stem cell transplantation will be investigated. These are patient where the leukemia has returned after the transplantation.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Diagnosis of acute myeloid leukemia with NPM1 mutations or KMT2A rearrangements
• Hematological relapse after allo-HCT
• 18 years or older
Locations
Other Locations
Germany
University of Freiburg Mdical Center
RECRUITING
Freiburg Im Breisgau
Contact Information
Primary
Robert Zeiser, MD
robert.zeiser@uniklinik-freiburg.de
+4976127034020
Time Frame
Start Date: 2026-05-30
Estimated Completion Date: 2027-05-30
Participants
Target number of participants: 20
Treatments
AML with NPM1 mutations or KMT2A rearrangements
AML with NPM1 mutations or KMT2A rearrangements that will be treated with immunotherapy (DLI) and immunmodulatory drugs recommended by the guidelines.
Related Therapeutic Areas
Sponsors
Leads: University of Freiburg